2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$18.81-$0.01 (-0.05%)
Price as of Jul 14, 2026 7:37 AM EDT- $2.0BMarket Cap
- -2.13%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$18.81-$0.01 (-0.05%)
SRPT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.82 | ||
Change | -$0.13 (-0.69%) | ||
Open | $18.97 | ||
High | $19.36 | ||
Low | $18.52 | ||
Previous Close | $18.95 | ||
Volume | 2,457,719 | ||
30-Day Average Volume | 4,104,939 | ||
1-Week Change | -1.88% | ||
1-Month Change | 22.93% | ||
1-Year Change | -2.13% | ||
3-Year Change | -82.65% | ||
5-Year Change | -72.83% | ||
Fundamentals | |||
Shares Outstanding | 105.6M | ||
Total Assets | $3.2B | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $730.8M | ||
Net Income | $331.0M | ||
Free Cash Flow | -$204.8M | ||
EBIT | $364.9M | ||
EBITDA | $375.5M | ||
Net Working Capital | $1.8B | ||
EPS | $2.88 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | 7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue